| Patents for A61P 35 - Antineoplastic agents (221,099) |
|---|
| 06/02/2011 | US20110130447 Production of hop extracts having oestrogenic and antiproliferative bioactivity |
| 06/02/2011 | US20110130446 Injectable taxane pharmaceutical composition |
| 06/02/2011 | US20110130437 Salt forms of a 6-fluoro-1,2-dihydro-2-oxo-3h-indol-3-ylidene derivative, process for their manufacture and pharmaceutical compositions containing same |
| 06/02/2011 | US20110130436 Caspase inhibitors and uses thereof |
| 06/02/2011 | US20110130418 Substituted phenylenediamines as inhibitors of the interaction between mdm2 and p53 |
| 06/02/2011 | US20110130414 Novel fused thiazolo and oxazolo pyrimidinones |
| 06/02/2011 | US20110130412 Acyclic amine inhibitors of nucleoside phosphorylases and hydrolases |
| 06/02/2011 | US20110130409 Substituted 1,2,3,4-tetrahydrocyclopenta[b]indol-3-yl)acetic acid derivatives useful in the treatment of autoimmune and inflammatory disorders |
| 06/02/2011 | US20110130406 Pyrazolo-pyridines as tyrosine kinase inhibitors |
| 06/02/2011 | US20110130404 Quinoxalinedione derivatives |
| 06/02/2011 | US20110130401 New chemical compounds |
| 06/02/2011 | US20110130399 Phthalazine Derivatives with Angiogenesis Inhibiting Activity |
| 06/02/2011 | US20110130398 Spiroindolinone pyrrolidines |
| 06/02/2011 | US20110130396 Imidazothiadiazole derivatives |
| 06/02/2011 | US20110130395 P13k isoform selective inhibitors |
| 06/02/2011 | US20110130394 Pharmaceutical compounds |
| 06/02/2011 | US20110130393 Inhibitors of janus kinases |
| 06/02/2011 | US20110130391 Ureido substituted benzoic acid compounds and their use for nonsense suppression and the treatment of disease |
| 06/02/2011 | US20110130386 Dna-pk inhibitors |
| 06/02/2011 | US20110130380 Heteroaryl Kinase Inhibitors |
| 06/02/2011 | US20110130378 Ezetimibe process and composition |
| 06/02/2011 | US20110130376 New no releasing steroids derivatives |
| 06/02/2011 | US20110130374 Small Pyrimidine Derivatives and Methods of Use Thereof |
| 06/02/2011 | US20110130368 Derivatives of 4- or 5-aminosalicylic acid |
| 06/02/2011 | US20110130367 Combination Therapy for Treating Proliferative Diseases |
| 06/02/2011 | US20110130363 Benzopyran and benzoxepin pi3k inhibitor compounds and methods of use |
| 06/02/2011 | US20110130362 A2b adenosine receptor antagonists |
| 06/02/2011 | US20110130361 Silicon derivatives as histone deacetylase inhibitors |
| 06/02/2011 | US20110130359 Methods for preventing or reducing neurotoxicity associated with administering dpd inhibitors in combination with 5-fu and 5-fu prodrugs |
| 06/02/2011 | US20110130358 Method for transdifferentiation of body tissues |
| 06/02/2011 | US20110130354 Sulfated oligosaccharide derivatives |
| 06/02/2011 | US20110130353 Highly purified antiendotoxin compound |
| 06/02/2011 | US20110130344 Tight junction protein modulators and uses thereof |
| 06/02/2011 | US20110130343 Immunity-inducing agent and method for detection of cancer |
| 06/02/2011 | US20110130342 Peptide homing to brain tumors |
| 06/02/2011 | US20110130341 Method and kit for detection of cancer, and therapeutic agent for cancer |
| 06/02/2011 | US20110130340 Methods of identifying anti-cancer agents and uses thereof |
| 06/02/2011 | US20110130327 Multi-Arm Amines and Uses Thereof |
| 06/02/2011 | US20110130324 Methods for systematic control of protein stability |
| 06/02/2011 | US20110129550 Cancer treatment method |
| 06/02/2011 | US20110129549 Tricyclic benzo[5,6]cyclohepta[1,2-b]pyridine derivatives and uses thereof |
| 06/02/2011 | US20110129537 Functionalized metal-coated energy converting nanoparticles, methods for production thereof and methods for use |
| 06/02/2011 | US20110129533 Porous drug matrices and methods of manufacture thereof |
| 06/02/2011 | US20110129524 Therapeutic agent for cancer, and method for treatment of cancer |
| 06/02/2011 | US20110129521 Pharmaceutical composition containing a hypomethylating agent and a histone deacetylase inhibitor |
| 06/02/2011 | US20110129503 Tumor vaccination in combination with hematopoietic cell transplantation for cancer therapy |
| 06/02/2011 | US20110129499 Dual delivery system for heterologous antigens |
| 06/02/2011 | US20110129496 Use of mTOR Inhibitors to Enhance T Cell Immune Responses |
| 06/02/2011 | US20110129483 Membrane transporter NaPi2b (SCL34A1) epitope for antibody therapy, antibodies directed thereto, and target for cancer therapy |
| 06/02/2011 | US20110129482 Polypeptide compounds for inhibiting angiogenesis and tumor growth |
| 06/02/2011 | US20110129481 Antibody specifically binding to c-Met and methods of use |
| 06/02/2011 | US20110129480 Anti-ferroportin 1 monoclonal antibodies and uses thereof |
| 06/02/2011 | US20110129478 Pharmaceutical composition for treatment and prevention of cancer |
| 06/02/2011 | US20110129474 Methods And Systems For Multi-Antibody Therapies |
| 06/02/2011 | US20110129473 Vhnar anti-cytokine domains |
| 06/02/2011 | US20110129471 Chronic lymphocytic leukemia cell line |
| 06/02/2011 | US20110129470 Use of specifically engineered enzymes to enhance the efficacy of prodrugs |
| 06/02/2011 | US20110129467 Therapeutic combination comprising an aurora kinase inhibitor and antiproliferative agents |
| 06/02/2011 | US20110129466 Methods of treating cancer by administering antibodies to cd200 |
| 06/02/2011 | US20110129464 Humanized anti-erbb2 antibodies and treatment with anti-erbb2 antibodies |
| 06/02/2011 | US20110129463 Quinazolin-4(3A)-One Derivatives and Methods of Use Thereof |
| 06/02/2011 | US20110129461 Mat II Beta Subunit RNAi and Therapeutic Methods Using Same |
| 06/02/2011 | US20110129457 Variant hhip1 protein and methods and uses thereof |
| 06/02/2011 | US20110129456 Sequential Administration of Chemotherapeutic Agents for Treatment of Cancer |
| 06/02/2011 | US20110129455 Inhibitors of akt activity |
| 06/02/2011 | US20110129448 Methods to mobilize progenitor/stem cells |
| 06/02/2011 | US20110129447 Methods for Cell Expansion and Uses of Cells and Conditioned Media Produced Thereby for Therapy |
| 06/02/2011 | US20110129446 Clone of newcastle disease virus, its manufacture and its application in the medical treatment of cancer |
| 06/02/2011 | US20110129445 Combinations comprising methotrexate and dhodh inhibitors |
| 06/02/2011 | US20110129440 Heterocyclic Urea and Thiourea Derivatives and Methods of Use Thereof |
| 06/02/2011 | US20110129423 Anticancer compounds and screening method |
| 06/02/2011 | US20110129422 Viscous Terpolymers as Drug Delivery Platform |
| 06/02/2011 | US20110129421 Matrix metalloprotease targeting nucleic acids |
| 06/02/2011 | US20110129418 Brain Tumor Targeting Peptides and Methods |
| 06/02/2011 | US20110129417 Administrable compositions |
| 06/02/2011 | US20110129416 Recombinant monoclonal antibodies and corresponding antigens for colon and pancreatic cancers |
| 06/02/2011 | US20110129412 Antibodies Directed to CD20 and Uses Thereof |
| 06/01/2011 | EP2327775A2 Therapy for alpha-galactosidase a deficiency |
| 06/01/2011 | EP2327705A1 Podophyllotoxins as antiproliferative agents |
| 06/01/2011 | EP2327697A1 The salts of n-ý4-(1-cyanocyclopentyl)phenyl¨-2-(4-pyridyl methyl)amino-3-pyridinecarboxamide |
| 06/01/2011 | EP2327690A1 Tricyclic compound |
| 06/01/2011 | EP2327451A2 Method for detecting and inhibiting angiogenesis |
| 06/01/2011 | EP2327418A1 Recombinant parainfluenza virus expression systems and vaccines comprising heterologous antigens derived from other viruses |
| 06/01/2011 | EP2327413A1 Pharmaceutical composition comprising FGF18 and IL-1 antagonist and method of use |
| 06/01/2011 | EP2327409A1 Tetracycline compound having target therapeutic activities |
| 06/01/2011 | EP2327408A1 Tetracyclic cyclic gmp-specific phosphodiesterase inhibitors for the treatment of benign prostatic hypertrophy |
| 06/01/2011 | EP2326718A1 Inhbb epitope peptides and vaccines containing the same |
| 06/01/2011 | EP2326668A1 Anti-il-12/il-23 antibodies |
| 06/01/2011 | EP2326653A1 New (poly)aminoalkylaminoalkylamide, alkyl-urea, or alkyl-sulfonamide derivatives of epipodophyllotoxin, a process for preparing them, and application thereof in therapy as anticancer agents |
| 06/01/2011 | EP2326649A1 Novel pyrrolo ý2,3-a¨carbazoles and use thereof as pim kinase inhibitors |
| 06/01/2011 | EP2326647A1 6-substituted 2-(benzimidazolyl)purine and purinone derivatives and 6-substituted 2-(imidazoioý4,5- c¨pyridinyl)purine and purinone derivatives for immunosuppression |
| 06/01/2011 | EP2326646A1 Purine derivatives for use in the treatment of allergic, inflammatory and infectious diseases |
| 06/01/2011 | EP2326645A1 Compound with serotoninergic activity, process for preparing it and pharmaceutical composition comprising it |
| 06/01/2011 | EP2326641A2 Polycyclic heteroaryl substituted triazoles useful as axl inhibitors |
| 06/01/2011 | EP2326636A2 Pyrazole carboxamide inhibitors of factor xa |
| 06/01/2011 | EP2326631A2 Mif modulators |
| 06/01/2011 | EP2326622A1 Cycloalkylidene and heterocycloalkylidene histone deacetylase inhibitor compounds |
| 06/01/2011 | EP2326350A2 Methods for killing psma-expressing, taxane-resistant cancer cells |
| 06/01/2011 | EP2326329A1 Antineoplastic combinations of 4-anilino-3-cyanoquinolines and capecitabine |
| 06/01/2011 | EP2326320A1 2, 4-disulfonyl pheny tert-butyl nitrone for the treatment of gliomas |